Tirzepatide, a GLP-1 medication already on the market to treat diabetes, is now FDA approved to help those suffering from ...

Sleep apnea affects over 29 million Americans, with Obstructive Sleep Apnea (characterized by pauses in breathing during ...

Obstructive sleep apnea is caused by the collapse of the upper ... are usually recommended for people with OSA who also have obesity. The newer drugs used to treat obesity may play an increasingly ...

Turkey: A recent study published in The Laryngoscope revealed a significant relationship between laryngopharyngeal reflux ...

Finding it hard to breathe when you lay down is medically called orthopnea. Find a list of potential causes to help narrow down your overall risk here.

The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...

Uratex Philippines, the country’s leading sleep solutions provider, has officially partnered with the Philippine Society of Sleep Medicine, Inc. (PSSM) to address the growing problem of sleep ...

In the wake of the U.S. Food and Drug Administration’s approval of Zepbound to treat moderate to severe obstructive sleep ...

the association of daytime hypercapnia and obesity, obstructive airflow limitation, restrictive lung impairment, and severity of sleep apnea; and the response to continuous positive airway ...

Background: A 60-year-old male with obesity (body-mass index 43 kg/m 2) presented with recurrent symptomatic atrial fibrillation (AF), which he had had since age 41 years. The AF was refractory to ...

The inking ceremony, held at Uratex Alabang with the theme “Partnering to Provide Quality Sleep for Filipinos,” marked the ...

Staying active boosts your heart health, strengthens muscles and bones, and helps manage weight. It improves sleep, reduces ...